Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Progranulin Gene Therapy Improves Lysosomal Dysfunction and Microglial Pathology Associated with Frontotemporal Dementia and Neuronal Ceroid Lipofuscinosis

29 Jan 2018

Abstract excerpt

Loss-of-function mutations in progranulin, a lysosomal glycoprotein, cause neurodegenerative disease. Progranulin haploinsufficiency causes frontotemporal dementia (FTD) and complete progranulin deficiency causes CLN11 neuronal ceroid lipofuscinosis (NCL). Progranulin replacement is a rational therapeutic strategy for these disorders, but there are critical unresolved mechanistic questions about a progranulin...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis Research
Share to Neurogenetic and Muscular Disorders Research
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29378861
DOI: 10.1523/jneurosci.3081-17.2018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Progranulin Gene Therapy Improves Lysosomal Dysfunction and Microglial Pathology Associated with Frontotemporal Dementia and Neuronal Ceroid LipofuscinosisPMID 29378861Read ↗

AAV-mediated progranulin delivery to a mouse model of progranulin deficiency causes T cell-mediated hippocampal degenerationSemantic proximity Read ↗

Loss of Progranulin Results in Increased Pan-Cathepsin Activity and Reduced LAMP1 Lysosomal ProteinSemantic proximity Read ↗

Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis.Semantic proximity Read ↗

Adeno-associated virus serotype 1-based gene therapy for FTD caused by GRN mutations.Semantic proximity Read ↗

Genetic Regulation of Neuronal Progranulin Reveals a Critical Role for the Autophagy-Lysosome PathwaySemantic proximity Read ↗

Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations.Semantic proximity Read ↗

Outcomes of Progranulin Gene Therapy in the Retina are Dependent on Time of DeliverySemantic proximity Read ↗

Microglia regulate brain progranulin levels through the endocytosis/lysosomal pathwaySemantic proximity Read ↗

Progranulin deficiency in the brain: the interplay between neuronal and non-neuronal cellsSemantic proximity Read ↗

Microglial Progranulin: Involvement in Alzheimer’s Disease and Neurodegenerative DiseasesSemantic proximity Read ↗

Microglial lysosome dysfunction contributes to white matter pathology and TDP-43 proteinopathy in GRN-associated FTDSemantic proximity Read ↗

Selective neuronal restoration of progranulin does not prevent the frontotemporal dementia like-phenotype of progranulin knockout mice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.